Genetic test for breast cancer approved
By MedHeadlines • Jul 14th, 2008 • Category: Breast Cancer, Cancer, FDA, Genetics, Women's HealthThe US Food and Drug Administration (FDA) has just announced approval of a genetic test that will help determine which breast cancer patients will be best served by taking the drug Herceptin (trastuzumab) for treatment. The new test, SPOT-Light HER2…